Intermediate Bone Neoplasm — Trials

Intermediate Bone Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

22 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03449108	LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas	active not recruiting	Phase 2	30	M.D. Anderson Cancer CenterOTHER	1	May 22, 2026	clinicaltrials
NCT04586660	Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone	active not recruiting	Phase 4	36	AmgenINDUSTRY	2	Oct 1, 2025	clinicaltrials

Data updated 22 days agoSource updated May 22, 2026source: clinicaltrials